New Findings
Introduction
Uncoupling proteins (UCPs) are located in the inner mitochondrial membrane. These proteins belong to a superfamily of mitochondrial ion transporters (Arsenijevic et al. 2000) . Among them are UCP2 and UCP3, which are expressed in the heart (Fleury et al. 1997; Arsenijevic et al. 2000; Brookes et al. 2008 ). Both mitochondrial proteins were shown to reduce cardiac reactive oxygen species (ROS) generation (Teshima et al. 2003; McLeod et al. 2005; Toime & Brand, 2010) . Thus, they are speculated to influence ischaemia-reperfusion injury and to improve cardiac recovery after ischaemia (Teshima et al. 2003; Ozcan et al. 2013; Perrino et al. 2013; Safari et al. 2014 ). Furthermore, a potential impact on cardiac electrophysiology is speculated in the literature. ECG studies in humans revealed an association of different UCP2/UPC3 polymorphisms and heart rate variability (Shin & Moritani, 2008; Matsunaga et al. 2009 ). Importantly, a genetic knockout promotes the incidence of ischaemia-reperfusion arrhythmias (Ozcan et al. 2013) .
Alteration of intracellular Ca 2+ handling is a major pathophysiological mechanism of various cardiac pathologies. In particular, increases in intracellular Ca 2+ concentrations are known to provoke triggered activity and, similar to variations in cardiac UCP expression, to promote ischaemia-reperfusion arrhythmias .
Various physiological mechanisms control Ca 2+ homeostasis in the heart. L-Type Ca 2+ channels (LTCCs) open upon depolarization, and therefore regulate the Ca 2+ -induced Ca 2+ release from the sarcoplasmic reticulum (SR) via ryanodine receptors (RyRs; Callewaert, 1992) . Ca 2+ reuptake is transmitted via sarco/endoplasmic reticulum Ca 2+ -ATPase (SERCA) and sodium-calcium exchangers (NCX) in the plasma membrane (Callewaert, 1992) . Mitochondria were recently reported to influence cardiac Ca 2+ handling through their ability to sequester Ca 2+ (Maack et al. 2006; Motloch et al. 2016b) .
Mitochondrial Ca 2+ uptake is mostly driven by the mitochondrial calcium uniporter (MCU; Kirichok et al. 2004; Michels et al. 2009; Hoppe, 2010; Bondarenko et al. 2013 Bondarenko et al. , 2014 Waldeck-Weiermair et al. 2015) . Cardiac UCP isoforms were shown to modulate MCU function and, for this reason, suggested to influence cytosolic Ca 2+ handling (Trenker et al. 2007; Hoppe, 2010; Waldeck-Weiermair et al. 2010a ,b, 2013 De Marchi et al. 2011; Bondarenko et al. 2015; Motloch et al. 2015b Motloch et al. , 2016a Madreiter-Sokolowski et al. 2016) . Accordingly, Ucp2 knockout (Ucp2 −/− ) mice were demonstrated to exhibit decreased MCU activity and, therefore, a reduced mitochondrial Ca 2+ uptake (Trenker et al. 2007; Motloch et al. 2016b) . Along with these observations, various alterations of cardiac cytosolic Ca 2+ handling were recorded (Motloch et al. 2016b) . These findings suggested changes in RyR kinetics to be a protective mechanism that prevents toxic Ca 2+ overload in the absence of UCP2 (Motloch et al. 2016b) . However, the specific regulatory mechanisms and their potential input in cardiac electrophysiology are incompletely understood.
Thus, to clarify this issue, we evaluated the expression of key Ca 2+ -handling proteins, LTCC activity and further electrophysiological characteristics in Ucp2 −/− and wild-type (WT) control animals. Furthermore, LTCCs were activated by Bay K 8644 to simulate Ca 2+ -overload-mediated stress in these animals. Our results show a new compensatory mechanism in Ucp2 −/− mice, namely that decreased mitochondrial Ca 2+ uptake is compensated for by functional inhibition of LTCCs and resultant shortening of the action potential duration (APD). Furthermore, Ucp2 −/− mice demonstrated a major impact on cardiac electrophysiology, with an increased susceptibility to Ca 2+ -mediated ventricular arrhythmias.
R. Larbig and others

Methods
Ethical approval
The study was approved by the governmental animal experiments committee in Salzburg according to the Austrian guidelines for the care and use of laboratory animals (no. 20901-TVG/80/12-2014) . The implementation of the experiments conformed to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH publication no. 85-23, revised 1996) and was compliant with the Austrian and EU guidelines for the care and use of laboratory animals mandated by the Paracelsus Medical University. The investigators declare that they understand the ethical principles under which Experimental Physiology operates and that their work complies with its animal ethics checklist (Grundy, 2015) .
Origin and source of the animals
The animals used in this study were males between 4 and 12 weeks of age, 20-30 g in weight. The mouse strain B6.129S4-Ucp2 tm1Lowl /J (Ucp2 −/− ; n = 63) was purchased from Charles River Laboratories, Research Models and Services, Germany (Pi et al. 2009 ). The identical background strain was acquired as the control (WT; n = 51).
Animal housing and access to food and water
Animals were housed in the facilities of the Paracelsus Medical University, Salzburg, Austria and the University Clinic of Münster, Germany. Food and water were provided ad libitum in the animal facilities.
Anaesthetic protocol and terminal procedure
Animals were anaesthetized using ketamine (100 mg kg −1 ) and xylazine (5 mg kg −1 ) I.P. Deep anaesthesia was confirmed by the absence of the palpebral reflex, and the animals were killed by cervical dislocation.
Molecular analysis of important Ca 2+ -handling proteins
Mice were killed and the hearts harvested. Hearts were washed in ice-cold Krebs-Henseleit buffer until blood ceased to drip out. Afterwards, hearts were dried on paper towels by gentle quenching and immediately frozen in liquid nitrogen. The hearts were ground with a mortar and pestle under constant cooling with liquid nitrogen. Proteins were extracted with the Qproteome Cell Compartment Kit (#37502; Qiagen, Venlo, The Netherlands). Briefly, ground hearts were resuspended in 1 ml of Buffer CE1 supplemented with protease inhibitors and sonicated (five times for 5 min each). Afterwards, soluble and membrane fractions were isolated according to the manufacturer's instructions. Both fractions were pooled and precipitated with four volumes of acetone for 2 h. Proteins were pelleted for 15 min in a cooled tabletop centrifuge (17 000 g) and the pellets washed twice with ice-cold acetone. Protein concentration was determined using the BCA Protein Assay Kit (#23225; Pierce, Thermo Fisher Scientific, Richarson, TX, USA). Pellets were resuspended in Laemmli buffer, and 30 μg of protein was subjected to SDS-PAGE. For detection of Na + -K + -ATPase, SERCA2a and LTCC, a 10% resolving gel was used. For detection of NCX1, an 8% resolving gel was used. For detection of RyR2, a 6% resolving gel was used.
Proteins were transferred onto nitrocellulose membranes by wet transfer. Membranes were washed, blocked in 5% non-fat dry milk-Tris buffered saline with Tween-20 (TBST) (0.1%) for 1 h and incubated with the primary antibodies [in 5% non-fat dry milk-TBST (0.1%)] for 2 h (rabbit anti-Na-K-ATPase 1, 1:500, #3010S, Cell Signaling Technology, Danvers, MA, USA; goat anti-SERCA2 C-20, 1:100, sc-8094, Santa Cruz Biotechnology, Dallas, TX, USA; mouse anti-calcium channel L type DHPR alpha 2 subunit, 1:100, ab2864, Abcam, Cambridge, UK; mouse anti-NCX1, 1:100, ab6495, Abcam; and mouse anti-ryanodine receptor, 1:100, ab2868, Abcam). Afterwards, membranes were washed and incubated with respective secondary antibodies [in 5% non-fat dry milk-TBST (0.1%)] coupled to horseradish peroxidase for 1 h (anti-goat IgG, 1:10 000, ab97110, Abcam; anti-rabbit IgG, 1:10 000, #7074S, Cell Signaling Technology; and anti-mouse IgG, 1:5000, #7076S, Cell Signaling Technology). ECL substrate (#32106; Thermo Scientific, MA, USA) was applied, and blots were recorded on a Stella Imaging System (Raytest, Straubenhardt, Germany).
Protein quantification was performed using the public domain ImageJ (National Institutes of Health, Bethesda, MD, USA) image processing program. Western blot figures were imported and the lanes set manually. After plotting the lanes as curves, bands were displayed as peaks with a defined area under the curve. To obtain a numerical value, the beginning and the end of the peaks were defined and the area under the curve and its percentage value obtained. Quantities of the proteins of interest were normalized by the results of the housekeeping protein Na + -K + -ATPase.
Determination of LTCC current
Wild-type or Ucp2 −/− mice were killed and their hearts harvested. Single ventricular myocytes were isolated from murine hearts by enzymatic digestion, as previously described Lange et al. 2003; Motloch et al. 2016b) . The LTCCs were measured UCP2 modulates cardiac electrophysiology using the standard microelectrode whole-cell patch-clamp technique at room temperature (21-23°C). Currents were recorded and digitized with an Axopatch 200B amplifier and Digidata 1322 interface (Molecular Devices, Sunnyvale, CA, USA) while being sampled at 10 kHz and filtered at 2 kHz Er et al. 2003; Brandt et al. 2009; Motloch et al. 2016b) . The recording bath and pipette solutions were applied as previously reported (Motloch et al. 2016b) . Borosilicate microelectrodes had tip resistances of 2-4 M when filled with pipette solution. The fire-polished electrodes had a tip diameter of 2-3 μm. We applied series resistance compensation to all recordings. Inward sodium currents were inhibited using a rectangular prepulse from −75 to −40 mV. We waited ß1 min before recordings were initiated. The LTCC was elicited with a series of subsequent rectangular pulses with a duration of 300 ms and a voltage ranging from −40 to 50 to −75 mV in 10 mV increments. To avoid possible run-down (Kameyama et al. 1988) , each recording was obtained within a maximum of 2 min.
Recording of action potentials, after-depolarizations and resting membrane potentials in isolated cardiomyocytes
Wild-type or Ucp2
−/− mice were killed and their hearts harvested. Single ventricular myocytes were isolated from murine hearts by enzymatic digestion, as previously described Lange et al. 2003; Motloch et al. 2016b) . To record cellular action potentials, we placed the cells in an experimental chamber (0.5 ml) mounted on the stage of an inverted microscope (Zeiss Axiovert 200; Carl Zeiss, Jena, Germany). A room temperature bath solution (20-22°C) continuously perfused the chamber. Patch electrodes were pulled from borosilicate glass on a Sutter P-97 horizontal puller (Sutter Instruments, Novato, CA, USA). The fire-polished electrodes had a tip diameter of 2-3 μm and a resistance of 2-4 MΩ when filled with the patch electrode solution, which contained (mM): 127 KCl, 10 Hepes, 10 NaCl, 0.1 cAMP and 5 MgATP. This solution was used to record action potentials during experiments. We used either a HEKA EPC-10 patch-clamp amplifier (HEKA, Bellmore, NY, USA) which was controlled by PatchMaster v2x53 software (HEKA) or an Axopatch 200B amplifier with a Digidata 1200B interface (MDS Analytical Technologies, Toronto, Canada), which was controlled by pClamp 9 software (MDS Analytical Technologies).
To record cellular action potentials, cardiomyocyte membranes were sealed with the borosilicate pipettes. After membrane rupture, the current-clamp configuration was established. We waited ß1 min before recordings were initiated. Action potentials were recorded at 0.5 Hz and 2.0 Hz. Up to four action potentials were recorded at each frequency. We measured APD 90 , membrane resting potential and action potential upstroke velocity (indicated by the slope factor of the cellular action potential upstroke) and evaluated the recordings for the occurrence of after-depolarizations (Er et al. 2004; Pott et al. 2005; Davis et al. 2012) .
ECG recording
Experiments were performed as previously reported (Knollmann et al. 2003) . Briefly, WT or Ucp2 −/− mice were anaesthetized with ketamine (100 mg kg −1 I.P.) and xylazine (5 mg kg −1 I.P.), and bipolar limb lead ECGs were recorded. Animals were placed on a heating pad to adjust body temperature to 37°C, which was monitored continuously using an anal probe. After confirmation of deep anaesthesia, mice were first allowed to rest for 5 min under ECG monitoring. Saline 0.9% [0.5 ml (25 g)
−1 ] or Bay K 8644 [0.11 mg kg −1 in 0.5 ml 0.9% saline (25 g) Carlsson et al. 1996 ] was injected I.P., followed by ECG recording for an additional 15 min, after which animals were killed by cervical dislocation.
ECG data analysis
ECGs were recorded and analysed using the PowerLab/4SP T System software (AD Instruments, Oxford, UK) for RR, PR, QRS and QT intervals. All parameters were further revised manually in a blinded fashion without knowledge of the genotype, and QT interval was corrected for heart rate using the Bazett formula with an adjustment for mice (QTc) using PowerLab/4SP T System software (Mitchell et al. 1998) . Heart rate variability was calculated as the SD of the RR interval in each experiment (Pumprla et al. 2002) .
Ventricular arrhythmias were counted manually in a blinded fashion without knowledge of the genotype. Ventricular tachycardia was defined as a run of four or more consecutive ventricular extra beats (VEBs). Simple ventricular arrhythmia was defined as the occurrence of a singular VEB, a couplet, a triplet, a bigeminus or a trigeminus. Furthermore, in all simple ventricular arrhythmias the total number of ventricular beats was counted.
Molecular analysis of UCP3 and protein arginine methyl transferase 1 (PRMT1)
Wild-type and Ucp2 −/− mice were killed and their hearts harvested. The hearts were washed in ice-cold PBS and frozen in liquid nitrogen. Total protein extraction was performed using the RIPA lysis buffer system (#sc-24948; Santa Cruz Biotechnology, Dallas, TX, USA). The frozen hearts were cut and mixed with RIPA buffer, which was supplemented with proteinase inhibitors. Under constant homogenization, the tissue was incubated on ice for 30 min and centrifuged at 17 000 g at 4°C for 15 min to pellet the remaining tissue fraction. Finally, the supernatant comprising the dissolved proteins was transferred into a new centrifuge tube and frozen at −20°C for later usage.
Total protein concentration was determined by BCA Protein Assay Kit (#23225; Pierce, Thermo Fisher Scientific, Richarson, TX, USA) according to the manufacturer's guide.
For the detection of PRMT1, 20 μg of total protein was mixed with 4× Laemmli buffer (#161-0747; Bio-Rad, Philadelphia, PA, USA) and incubated for 5 min at 95°C for denaturation. The samples were put on ice and afterwards loaded onto a 4-15% Mini-PROTEAN TM TGX Stain-Free TM protein gel (#4568083; Bio-Rad). Precision Plus Protein TM Kaleidoscope TM Standard (#1610375; Bio-Rad) was used as a standard. Proteins were transferred onto Immun-Blot polyvinylidene fluoride membranes (#1620177; Bio-Rad) by a semi-dry blotting system. The total protein concentration was recorded by the ChemiDoc XRS+ System (#1708265; Bio-Rad). Membranes were washed with TBST and blocked with Roti R -Block blocking reagent (#A151.1; Carl Roth, Karlsruhe, Germany) for 1 h. After another washing step, the membranes were incubated with the primary antibody PRMT1 (1:1000 dilution in Roti R -Block; #2453; Cell Signaling Technology) overnight at 4°C. Membranes were washed and incubated with the appropriate secondary antibody (anti-rabbit IgG, HRP-linked antibody, 1:4000 dilution in Roti R -Block; #7074; Cell Signaling Technology) for 1 h at room temperature. After another washing step, Clarity Western ECL Substrate (#1705060; Bio-Rad) was added and the bands were detected by the ChemiDoc XRS+ System.
For the detection of UCP3, 10 μg of the total protein fraction was denatured for 10 min at 95°C to break up UCP3 dimers. Furthermore, for UCP3 detection, membranes were blocked with 5% non-fat dry milk-TBST (0.05%). The primary antibody, anti-UCP3 antibody (#ab3477, Abcam, Bristol, UK), and the secondary antibody were diluted in 5% non-fat dry milk-TBST (0.05%). In addition, Clarity Max TM Western ECL Substrate (#1705062S; Bio-Rad) was used instead of Clarity Western ECL Substrate.
Quantification of the proteins of interest was performed by total protein normalization using Image Lab TM Software (Bio-Rad).
Statistical analysis
In patch-clamp experiments, n refers to the number of patch-clamp experiments obtained in cardiomyocytes isolated from a minimum of three hearts. In all other experiments, n refers to the number of animals. Pooled data are presented as the median and range for ordinal variables or as the mean ± SD for rational variables. Comparisons between groups were performed with the χ 2 test for nominal variables, the Mann-Whitney U test for ordinal variables and Student's unpaired t test or one-way ANOVA for rational variables when appropriate. A value of P < 0.05 was regarded as significant.
Results
Expression of important Ca 2+ -regulatory proteins
A previous trial demonstrated various alterations of cardiac cytosolic Ca 2+ handling as protective against toxic Ca 2+ overload in Ucp2 −/− mice (Motloch et al. 2016b ). To evaluate this mechanism, we started by measuring the expression of key Ca 2+ -handling proteins (Callewaert, 1992) in the hearts of Ucp2 −/− and WT control mice. However, no differences in the expression of RyR2, SERCA2a, NCX1 or LTCC were noted (Fig. 1A) . As such, these data discount a major role for quantitative changes in protein expression in Ucp2 −/− mice.
Activity of LTCC in cardiomyocytes
We therefore hypothesized that functional changes in a key regulatory protein (or proteins) alter Ca 2+ handling in Ucp2 −/− mice. Of note, several of these mechanisms have already been investigated in a recent study (Motloch et al. 2016b (Motloch et al. 2016b ). These observations led to speculation that alterations of RyR kinetics might prevent toxic cytosolic Ca 2+ overload in Ucp2 −/− mice (Motloch et al. 2016b) . Importantly, in cardiomyocytes RyR function is regulated by Ca 2+ -induced Ca 2+ release, which depends on the activity of the LTCC, a major gatekeeper for Ca 2+ release in the heart (Callewaert, 1992) . Thus, we hypothesized that alterations in LTCC function might be the main driving force for previously described changes in cardiac Ca 2+ handling in Ucp2 −/− mice. Indeed, as shown in Fig. 1B , by using the whole-cell patch-clamp technique in isolated cardiomyocytes, we were able to record a significantly reduced LTCC current in Ucp2 −/− mice, indicating a specific compensatory mechanism to avoid intracellular Ca 2+ overload in Ucp2 −/− mice (WT at 0 mV, 5.59 ± 2.5 pA pF −1 versus Ucp2 −/− , 2.90 ± 0.9 pA pF −1 , P < 0.05; Fig. 1B ).
APD 90 , after-depolarizations, upstroke velocity and resting membrane potential in isolated cardiomyocytes
We then hypothesized that downregulation of the LTCC current might be associated with potential −/− , 21.6 ± 16 ms, P < 0.05; Fig. 1C and  D) . Additionally, we observed an increased incidence of after-depolarizations, especially arrhythmogenic delayed after-depolarizations, at 0.5 and 2.0 Hz in Ucp2 −/− versus WT cardiomyocytes [WT, 0 (0-0) versus Ucp2 −/− , 3 (0-5), P < 0.05; Fig. 2A and B] . Surprisingly, we also detected an increased upstroke velocity of phase 0 of the action potential in Ucp2 −/− cardiomyocytes (WT, 73.0 ± 63 mV ms
versus Ucp2 −/− , 246.6 ± 241 mV ms −1 , P < 0.05; Fig. 2C ), indicating alterations in cardiac excitability in Ucp2 −/− cardiomyocytes. Interestingly, we also observed a hyperpolarized resting membrane potential in Ucp2 −/− cardiomyocytes (WT, −81.8 ± 11 mV versus Ucp2 −/− , −103.9 ± 19 mV, P < 0.05; Fig. 2D ), which might indicate a counter-regulatory mechanism compensating for the increased occurrence of after-depolarizations in basal conditions.
ECG recordings
Based on our cellular findings, we speculated that UCP2 has an impact on in vivo cardiac electrophysiology. Therefore, ECGs were performed in Ucp2 −/− and WT control animals. Detailed ECG characteristics are present in Table 1 and Fig. 2E and F. Indeed, Abbreviations: LTCC, L-type Ca 2+ channel; NCX1, Na + -Ca 2+ exchanger 1; RyR2, ryanodine receptor 2; and SERCA2, sarco/endoplasmic reticulum Ca 2+ -ATPase. B, examples of representative original traces of LTCC currents (L-type I Ca ) using a testing potential of 0 mV and statistical analysis; current densities of I Ca were significantly decreased in Ucp2 −/− (n = 6) versus WT (n = 9), revealing a compensational mechanism to avoid intracellular Ca 2+ overload in Ucp2 −/− cardiomyocytes. C and D, analysis of action potential duration (APD) in cardiomyocytes from WT (n = 6) versus Ucp2 −/− mice (n = 7). C, examples of representative original APD traces. D, statistical analysis: APD 90 at 2 Hz revealed a significantly shortened APD in Ucp2 −/− cardiomyocytes; * P < 0.05 using Student's unpaired t test.
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Ucp2
−/− animals revealed significant alterations in cardiac electrophysiology, indicated by reductions in the PR, QRS and QTc intervals (Table 1 and Fig. 2E and F) . However, after saline injection, no ventricular arrhythmias in either WT or in Ucp2 −/− animals were noted. Therefore, we hypothesized that compensatory mechanisms in Ucp2 −/− animals might prevent ventricular arrhythmias in baseline conditions but not during Ca 2+ -mediated cellular stress. To evaluate a potential susceptibility for Ca 2+ -dependent arrhythmias, ECGs were monitored after injection with the specific LTCC activator Bay K 8644. Detailed characteristics of arrhythmic events after injection of Bay K 8644 are presented in Table 2 and Fig. 3 . Indeed, with an occurrence of 57% compared with 0% in WT mice, Ucp2 −/− animals presented a significantly higher incidence of ventricular tachycardia (Table 2 and Fig. 3A and B) . Furthermore, in Ucp2 −/− mice, simple ventricular arrhythmias were recorded consdierably more often (Table 2 and Fig. 3A and C) . These events revealed more complex characteristics, indicated by a significantly higher number of couplets and ventricular beats in all events ( Table 2) .
Expression of mitochondrial proteins
To investigate potential compensatory mechanisms in the mitochondria, the expression of UCP3 and PRMT1 was studied in WT and Ucp2 −/− mice, Interestingly, we did not observe any differences in expression of UCP3 (Fig. 4A) . However, PRMT1 levels were elevated in Ucp2 −/− hearts 
. Cellular electrophysiology and ECGs
A and B, analysis of the incidee of after-depolarizations in cardiomyocytes from WT (n = 6) versus Ucp2 −/− ice (n = 7). A, examples of representative original APD traces. B, statistical analysis. Ucp2 −/− cardiomyocytes presented a high incidence of after-depolarizations, whereas no incidents were observed in WT cardiomyocytes, indicating increased arrhythmogenicity in Ucp2 −/− cardiomyocytes; # P < 0.05 versus WT using the Mann-Whitney U test. Abbreviation: DADs, delayed after-depolarizations. C, upstroke velocity of the action potential indicated by the slope factor of the action potential upstroke was significantly elevated in Ucp2 −/− (n = 7) versus WT cardiomyocytes (n = 6), measured at a pacing rate of 0.5 Hz; * P < 0.05 using Student's unpaired t test. D, resting membrane potential (RMP) was significantly more hyperpolarized in cardiomyocytes from Ucp2 −/− (n = 7) versus WT mice (n = 6); * P < 0.05 using Student's unpaired t test. E and F, ECG analysis in WT (n = 7) versus Ucp2 −/− mice (n = 7). E, examples of representative original ECG traces. F, statistical analysis. The PR and QRS as well as the QTc intervals were shortened in Ucp2 −/− mice; * P < 0.05 using Student's unpaired t test. UCP2 modulates cardiac electrophysiology Values are means ± SD. * P < 0.05 versus wild type using Student's unpaired t test. 
Number of experiments 7 7
Characteristics of simple arrhythmias in wild-type and Ucp2 −/− mice during monitoring after injection of Bay K 8644 are indicated as the median (range) of the number of events. Abbreviations: SVA, simple ventricular arrhythmia defined as the occurrence of singular VEB, couplet, triplet, bigeminus or trigeminus; and VEB, ventricular extra beat. * P < 0.05 versus wild type using Mann-Whitney U test.
( Fig. 4B) , indicating a potential molecular mechanism that might promote decreased activity of the cardiac MCU in Ucp2 −/− mice (Motloch et al. 2016b) .
Discussion
The mitochondrial protein UCP2 was shown to modulate MCU function negatively, and therefore, implicated to influence cardiac cytosolic Ca 2+ handling (Trenker et al. 2007; Hoppe, 2010; Waldeck-Weiermair et al. 2010b Bondarenko et al. 2015; Motloch et al. 2015b Motloch et al. , 2016b . However, the amplitude of cytosolic Ca 2+ transients was not altered in Ucp2 −/− mice (Motloch et al. 2016b) . Given that cytosolic Ca 2+ overload is considered unfavourable because it is observed durig the onset of heart failure (Balke & Shorofsky, 1998) , compensatory mechanisms in these mice are likely.
Here, we tried to identify the specific regulatory mechanisms in Ucp2 −/− and WT control mice and to explore the potential impact of UCP2 on cardiac rhythm and different characteristics of cardiac electrophysiology. We succeeded in uncovering how Ucp2 −/− mice avoid cardiac cellular Ca 2+ overload. Importantly, we measured a reduced LTCC current, hence a shortened APD 90 , as well as a commensurate reduction of the QTc interval on the ECG in Ucp2 −/− mice. These data are in accordance with previous findings (Pott et al. 2005) . A reduced Ca 2+ entry through the LTCC should trigger less Ca 2+ -induced Ca 2+ release, preventing cytosolic Ca 2+ overload in the presence of reduced MCU activity in Ucp2 −/− mice as well as altering the kinetics of the RyR (Pott et al. 2005) . Indeed, alteration of cardiac RyR kinetics was suspected in Ucp2 −/− mice (Motloch et al. 2016b ). Similar modulations, in which reduced Ca 2+ influx and shortened APDs were observed as potential compensatory mechanisms against Ca 2+ overload, have been shown in NCX knockout mice (Pott et al. 2005) . These mice also survived to adulthood and only had a relatively modest reduction in cardiac function (Henderson et al. 2004) . Likewise, in pathophysiological conditions Ucp2 −/− mice show no obvious cardiac pathological phenotype (McDonald et al. 2008; Andrews & Horvath, 2009) , indicating that the observed compensatory mechanisms might provide sufficient protection against heart failure or arrhythmias in basal conditions.
To explore these speculations, further electrophysiological characteristics were studied. In this study, we observed unique electrophysiological variations leading to an increased susceptibility for Ca 2+ -dependent ventricular arrhythmias in Ucp2 −/− mice. To the best of our knowledge, this is the first report to demonstrate UCP2 as a modulator of cardiac electrophysiology. Importantly, we detected an increased occurrence of afterdepolarizations, especially proarrhythmic delayed afterdepolarizations, in Ucp2 −/− mice. Of note, after-depolarizations are associated with defective cardiac Ca 2+ cycling. They promote triggered activity and increase cardiac arrhythmogeneity .
Indeed, exposure of Ucp2 −/− mice to the LTCC activator Bay K 8644 elicited ventricular arrhythmias that can be presumed to result from increased cytosolic Ca 2+ and intracellular Ca 2+ overload (Carlsson et al. 1996; Zhang et al. 2002) . This suggests that in Ucp2 −/− mice, the uptake of Ca 2+ by mitochondria is sufficient to prevent ventricular arrhythmias in basal conditions but not in conditions of Ca 2+ overload. This speculation fits well with a previous report, which demonstrated a higher incidence of ischaemia-reperfusion arrhythmias in Ucp3 knockout animals (Ozcan et al. 2013) .
In addition, our results also suggest UCP2-dependent alterations in cardiac excitability. We detected an increased slope factor of the action potential upstroke in Ucp2 −/− cardiomyocytes, and therefore, probably also variations in cardiac conduction (King et al. 2013; . Indeed, in agreement with these speculations, R. Larbig and others decreased PR and QRS values were measured in Ucp2 −/− mice (Winterton et al. 1994) .
In contrast, as alterations of the slope factor of the action potential upstroke depend on sodium channel availability, these data could also hint at increased activity of the late sodium current. Of note, in addition to potential effects on myocardial excitability and conduction properties, this modification might also provoke triggered activity and promote vulnerability to ventricular arrhythmias (Akar & Hajjar, 2014; , as observed in Ucp2 −/− mice. However, in the present study we also measured a more hyperpolarized resting membrane potential in Ucp2 −/− cardiomyocytes. This surprising finding might indicate an additional counter-regulatory mechanism; namely, that this hyperpolarized membrane state could protect against relevant depolarization by after-depolarizations, and therefore, counterbalance the risk for ventricular arrhythmias. This speculation is supported by the absence of arrhythmias in basal condition in Ucp2 −/− mice. Likewise, the more hyperpolarized membrane potential can be expected to decrease the fraction of inactivated voltage-dependent Na + channels, which could explain an increased slope factor of the action potential upstroke in Ucp2 −/− cardiomyocytes (Rook et al. 1999) . However, as sodium channel function and cardiac conduction velocity were not specifically investigated in the present study, these speculations should be considered with caution. Notably, the hyperpolarized membrane potential underlines the profound electrophysiological alterations in Ucp2 −/− cardiomyocytes; although a hyperpolarized membrane potential is expected primarily to increase the driving force for Ca 2+ through the LTCC, we found the opposite to be true. This surprising outcome may be attributable to a a counter-regulatory mechanism caused by elevated dyadic cleft Ca 2+ and increased Ca 2+ -dependent inactivation of and a higher number of simple ventricular arrhythmias (C) were observed in Ucp2 −/− mice, indicating a higher susceptibility to Ca 2+ -mediated arrhythmias. Simple ventricular arrhythmia was defined as the occurrence of singular ventricular extra beat, couplet, triplet, bigeminus or trigeminus; $ P < 0.05 versus WT using the χ 2 test and # P < 0.05 versus WT using the Mann-Whitney U test. UCP2 modulates cardiac electrophysiology the LTCC to protect Ucp2 −/− cardiomyocytes against Ca 2+ overload. One should also consider another mechanism by which UCP2 might affect cardiac electrophysiology. Aside from its impact on mitochondrial Ca 2+ uptake, UCP2 was shown to influence cardiac ROS expression (Teshima et al. 2003; McLeod et al. 2005) . UCP2 overexpression was demonstrated to reduce cardiac ROS (Teshima et al. 2003) , and consistently, genetic silencing of this protein has been shown to increase ROS concentrations (McLeod et al. 2005; Andrews & Horvath, 2009 ). Therefore, increased activity of the sarcolemmal ATP-dependent K + channel in Ucp2
hearts is likely. Indeed, activation of this ATP-dependent channel by ROS is known to promote APD shortening and to reduce cardiac Ca 2+ influx (Brown & O'Rourke, 2010; Akar & O'Rourke, 2011; Motloch et al. 2015a) . However, these speculations were not in the scope of investigation here and should be addressed in a subsequent study.
In our study, we were not able to detect any compensatory mechanisms in the mitochondria, because UCP3 expression was not altered. However, PRMT1 was upregulated. Of note, in their elegant proof-of-principle study, Madreiter-Sokolowski et al. (2016) were able to clarify controversies in UCP2 physiology. The authors demonstrated that regulatory effects of UCP2 on MCU are dependent on the activity of PRMT1, which decreases Ca 2+ sensitivity of MICU1 through asymmetric methylation (Madreiter-Sokolowski et al. 2016) . Consequently, upregulation of PRMT1 could explain decreased mitochondrial Ca 2+ uptake in Ucp2 −/− hearts (Motloch et al. 2016b) . These unique alterations of mitochondrial physiology may lead to speculations about further functional alterations that could promote a potential cardiac phenotype in Ucp2 −/− mice. Notably, through modulation of MCU function, the protein was speculated to serve as a regulator of the respiratory chain via the modulation of mitochondrial Ca 2+ uptake, indicating a physiological R. Larbig and others feedback mechanism in situations with high energy demands (Motloch et al. 2016b ). Thus, one may speculate that, especially in conditions of oxidative stress, cardiac ATP production is altered. Indeed, lower concentrations of ATP were observed in Ucp3 knockout mice subjected to ischaemia-reperfusion injury (Ozcan et al. 2013) . Therefore, also in Ucp2 −/− mice, a reduced resistance against cardiac hypoxia could be suggested. Furthermore, an impaired physical capacity could be speculated. These speculations are supported by further trials that demonstrated an increase in cardiac injury in Ucp3 knockout models (Ozcan et al. 2013; Perrino et al. 2013) as well as a decrease in the lifespan of mice in the absence of UCP2 (Andrews & Horvath, 2009 ). However, these considerations were not in the scope of the present study and should be addressed in subsequent trials.
Conclusion
In conclusion, our observations indicate compensatory mechanisms by which Ucp2 −/− mice prevent toxic cytosolic Ca 2+ overload in the presence of decreased MCU activity. UCP2-dependent modulations are of major impact on cardiac electrophysiology and influence susceptibility to Ca 2+ -mediated ventricular arrhythmias.
Limitations
Owing to species-dependent variations in cardiac electrophysiology, our results should be considered with caution in the context of human physiology (Mitchell et al. 1998) . Our study focused on alterations in cardiac electrophysiology only. Notably, as Ca 2+ is an important trigger for the mitochondrial respiratory chain, ATP production and cardiac haemodynamics could be altered in Ucp2 −/− mice. However, ATP content and further parameters of cardiac function in basal and working conditions were not investigated in our study. Anaesthetic drugs and deep sedation potentially affected our ECG results. Even so, the abolishment of sympathetic drive during deep sedation is likely to decrease Ca 2+ -mediated stress in basal conditions. As such, the incidence of ventricular arrhythmias in Ucp2 −/− mice is more likely to be underestimated in our experimental model.
